Do analysts rate ATPC or ACON?

Aclarion has a consensus target price of $7.50, indicating a potential upside of 122.55%. Given Aclarion's stronger consensus rating and higher probable upside, analysts clearly believe Aclarion is more favorable than Agape ATP. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Agape ATP 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Aclarion 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has higher valuation and earnings, ATPC or ACON?

Agape ATP has higher revenue and earnings than Aclarion. Agape ATP is trading at a lower price-to-earnings ratio than Aclarion, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Agape ATP $1.52M 2.72 -$2.28M -$1.33 N/A Aclarion $80K 103.63 -$7.23M -$9.03 N/A

Is ATPC or ACON more profitable?

Agape ATP has a net margin of -125.89% compared to Aclarion's net margin of -10,320.51%. Agape ATP's return on equity of -8.43% beat Aclarion's return on equity. Company Net Margins Return on Equity Return on Assets Agape ATP -125.89% -8.43% -7.75% Aclarion -10,320.51% -54.41% -51.71%

Does the media refer more to ATPC or ACON?

In the previous week, Aclarion had 3 more articles in the media than Agape ATP. MarketBeat recorded 7 mentions for Aclarion and 4 mentions for Agape ATP. Agape ATP's average media sentiment score of 1.22 beat Aclarion's score of 0.76 indicating that Agape ATP is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Agape ATP 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Aclarion 2 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer MGRX or ATPC?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Mangoceuticals 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Agape ATP 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is MGRX or ATPC more profitable?

Agape ATP has a net margin of -125.89% compared to Mangoceuticals' net margin of -4,639.13%. Agape ATP's return on equity of -8.43% beat Mangoceuticals' return on equity. Company Net Margins Return on Equity Return on Assets Mangoceuticals -4,639.13% -112.00% -104.96% Agape ATP -125.89% -8.43% -7.75%

Does the media prefer MGRX or ATPC?

In the previous week, Agape ATP had 1 more articles in the media than Mangoceuticals. MarketBeat recorded 4 mentions for Agape ATP and 3 mentions for Mangoceuticals. Agape ATP's average media sentiment score of 1.22 beat Mangoceuticals' score of 0.63 indicating that Agape ATP is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Mangoceuticals 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Agape ATP 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend ATPC or MRAI?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Agape ATP 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Marpai 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has preferable valuation and earnings, ATPC or MRAI?

Agape ATP has higher earnings, but lower revenue than Marpai. Agape ATP is trading at a lower price-to-earnings ratio than Marpai, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Agape ATP $1.52M 2.72 -$2.28M -$1.33 N/A Marpai $34.87M 0.54 -$28.75M -$0.87 N/A

Is ATPC or MRAI more profitable?

Marpai has a net margin of -85.70% compared to Agape ATP's net margin of -125.89%. Marpai's return on equity of 0.00% beat Agape ATP's return on equity. Company Net Margins Return on Equity Return on Assets Agape ATP -125.89% -8.43% -7.75% Marpai -85.70% N/A -100.23%

Does the media favor ATPC or MRAI?

In the previous week, Agape ATP had 1 more articles in the media than Marpai. MarketBeat recorded 4 mentions for Agape ATP and 3 mentions for Marpai. Agape ATP's average media sentiment score of 1.22 beat Marpai's score of 0.49 indicating that Agape ATP is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Agape ATP 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Marpai 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts prefer ATPC or ADVB?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Agape ATP 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Advanced Biomed 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Does the media favor ATPC or ADVB?

In the previous week, Agape ATP had 1 more articles in the media than Advanced Biomed. MarketBeat recorded 4 mentions for Agape ATP and 3 mentions for Advanced Biomed. Agape ATP's average media sentiment score of 1.22 beat Advanced Biomed's score of 1.16 indicating that Agape ATP is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Agape ATP 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Advanced Biomed 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate BGLC or ATPC?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BioNexus Gene Lab 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Agape ATP 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Does the media prefer BGLC or ATPC?

In the previous week, Agape ATP had 2 more articles in the media than BioNexus Gene Lab. MarketBeat recorded 4 mentions for Agape ATP and 2 mentions for BioNexus Gene Lab. Agape ATP's average media sentiment score of 1.22 beat BioNexus Gene Lab's score of 0.93 indicating that Agape ATP is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment BioNexus Gene Lab 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Agape ATP 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Trading of Agape ATP was halted at 09:46 AM EST due to "LULD Pause".

Agape ATP (ATPC) Competitors

$4.14 -0.73 (-14.99%)

Closing price 04:00 PM Eastern

Extended Trading

$4.18 +0.04 (+1.09%)

As of 06:15 PM Eastern

Compare

ATPC vs. ACON, MGRX, MRAI, ADVB, and BGLC

Should you buy Agape ATP stock or one of its competitors? MarketBeat compares Agape ATP with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Agape ATP include Aclarion (ACON), Mangoceuticals (MGRX), Marpai (MRAI), Advanced Biomed (ADVB), and BioNexus Gene Lab (BGLC). These companies are all part of the "healthcare" industry.

How does Agape ATP compare to Aclarion?

Agape ATP (NASDAQ:ATPC) and Aclarion (NASDAQ:ACON) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, risk, valuation, dividends, analyst recommendations, profitability, media sentiment and earnings.

Agape ATP has a net margin of -125.89% compared to Aclarion's net margin of -10,320.51%. Agape ATP's return on equity of -8.43% beat Aclarion's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Agape ATP	-125.89%	-8.43%	-7.75%
Aclarion	-10,320.51%	-54.41%	-51.71%

Aclarion has a consensus target price of $7.50, indicating a potential upside of 122.55%. Given Aclarion's stronger consensus rating and higher probable upside, analysts clearly believe Aclarion is more favorable than Agape ATP.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Agape ATP	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Aclarion	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

0.0% of Agape ATP shares are held by institutional investors. Comparatively, 7.5% of Aclarion shares are held by institutional investors. 2.0% of Agape ATP shares are held by company insiders. Comparatively, 0.0% of Aclarion shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Agape ATP has higher revenue and earnings than Aclarion. Agape ATP is trading at a lower price-to-earnings ratio than Aclarion, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Agape ATP	$1.52M	2.72	-$2.28M	-$1.33	N/A
Aclarion	$80K	103.63	-$7.23M	-$9.03	N/A

In the previous week, Aclarion had 3 more articles in the media than Agape ATP. MarketBeat recorded 7 mentions for Aclarion and 4 mentions for Agape ATP. Agape ATP's average media sentiment score of 1.22 beat Aclarion's score of 0.76 indicating that Agape ATP is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Agape ATP	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Aclarion	2 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Agape ATP has a beta of 0.05, suggesting that its share price is 95% less volatile than the broader market. Comparatively, Aclarion has a beta of 1.22, suggesting that its share price is 22% more volatile than the broader market.

Summary

Agape ATP and Aclarion tied by winning 8 of the 16 factors compared between the two stocks.

How does Agape ATP compare to Mangoceuticals?

Mangoceuticals (NASDAQ:MGRX) and Agape ATP (NASDAQ:ATPC) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, profitability, earnings, dividends, valuation, media sentiment, analyst recommendations and institutional ownership.

In the previous week, Agape ATP had 1 more articles in the media than Mangoceuticals. MarketBeat recorded 4 mentions for Agape ATP and 3 mentions for Mangoceuticals. Agape ATP's average media sentiment score of 1.22 beat Mangoceuticals' score of 0.63 indicating that Agape ATP is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Mangoceuticals	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Agape ATP	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Agape ATP has higher revenue and earnings than Mangoceuticals. Agape ATP is trading at a lower price-to-earnings ratio than Mangoceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Mangoceuticals	$460K	15.68	-$20.64M	-$1.49	N/A
Agape ATP	$1.52M	2.72	-$2.28M	-$1.33	N/A

Agape ATP has a net margin of -125.89% compared to Mangoceuticals' net margin of -4,639.13%. Agape ATP's return on equity of -8.43% beat Mangoceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Mangoceuticals	-4,639.13%	-112.00%	-104.96%
Agape ATP	-125.89%	-8.43%	-7.75%

Mangoceuticals has a beta of 2.27, indicating that its share price is 127% more volatile than the broader market. Comparatively, Agape ATP has a beta of 0.05, indicating that its share price is 95% less volatile than the broader market.

56.7% of Mangoceuticals shares are owned by institutional investors. Comparatively, 0.0% of Agape ATP shares are owned by institutional investors. 16.0% of Mangoceuticals shares are owned by insiders. Comparatively, 2.0% of Agape ATP shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Mangoceuticals	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Agape ATP	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Agape ATP beats Mangoceuticals on 8 of the 13 factors compared between the two stocks.

How does Agape ATP compare to Marpai?

Agape ATP (NASDAQ:ATPC) and Marpai (NASDAQ:MRAI) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, risk, valuation, dividends, institutional ownership, profitability, analyst recommendations and media sentiment.

Agape ATP has higher earnings, but lower revenue than Marpai. Agape ATP is trading at a lower price-to-earnings ratio than Marpai, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Agape ATP	$1.52M	2.72	-$2.28M	-$1.33	N/A
Marpai	$34.87M	0.54	-$28.75M	-$0.87	N/A

Marpai has a net margin of -85.70% compared to Agape ATP's net margin of -125.89%. Marpai's return on equity of 0.00% beat Agape ATP's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Agape ATP	-125.89%	-8.43%	-7.75%
Marpai	-85.70%	N/A	-100.23%

0.0% of Agape ATP shares are held by institutional investors. Comparatively, 49.8% of Marpai shares are held by institutional investors. 2.0% of Agape ATP shares are held by company insiders. Comparatively, 46.1% of Marpai shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Agape ATP has a beta of 0.05, meaning that its share price is 95% less volatile than the broader market. Comparatively, Marpai has a beta of 4.38, meaning that its share price is 338% more volatile than the broader market.

In the previous week, Agape ATP had 1 more articles in the media than Marpai. MarketBeat recorded 4 mentions for Agape ATP and 3 mentions for Marpai. Agape ATP's average media sentiment score of 1.22 beat Marpai's score of 0.49 indicating that Agape ATP is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Agape ATP	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Marpai	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Agape ATP	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Marpai	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Summary

Marpai beats Agape ATP on 8 of the 14 factors compared between the two stocks.

How does Agape ATP compare to Advanced Biomed?

Agape ATP (NASDAQ:ATPC) and Advanced Biomed (NASDAQ:ADVB) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, profitability, valuation, dividends, earnings, analyst recommendations, institutional ownership and risk.

Agape ATP has a beta of 0.05, indicating that its stock price is 95% less volatile than the broader market. Comparatively, Advanced Biomed has a beta of 0.68, indicating that its stock price is 32% less volatile than the broader market.

Advanced Biomed has a net margin of 0.00% compared to Agape ATP's net margin of -125.89%. Advanced Biomed's return on equity of 87.74% beat Agape ATP's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Agape ATP	-125.89%	-8.43%	-7.75%
Advanced Biomed	N/A	87.74%	64.49%

0.0% of Agape ATP shares are owned by institutional investors. 2.0% of Agape ATP shares are owned by insiders. Comparatively, 34.4% of Advanced Biomed shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Agape ATP	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Advanced Biomed	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Agape ATP has higher revenue and earnings than Advanced Biomed. Agape ATP is trading at a lower price-to-earnings ratio than Advanced Biomed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Agape ATP	$1.52M	2.72	-$2.28M	-$1.33	N/A
Advanced Biomed	N/A	N/A	-$3.26M	$4.82	0.91

In the previous week, Agape ATP had 1 more articles in the media than Advanced Biomed. MarketBeat recorded 4 mentions for Agape ATP and 3 mentions for Advanced Biomed. Agape ATP's average media sentiment score of 1.22 beat Advanced Biomed's score of 1.16 indicating that Agape ATP is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Agape ATP	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Advanced Biomed	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Advanced Biomed beats Agape ATP on 7 of the 12 factors compared between the two stocks.

How does Agape ATP compare to BioNexus Gene Lab?

BioNexus Gene Lab (NASDAQ:BGLC) and Agape ATP (NASDAQ:ATPC) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, media sentiment, earnings, dividends, profitability, valuation and risk.

In the previous week, Agape ATP had 2 more articles in the media than BioNexus Gene Lab. MarketBeat recorded 4 mentions for Agape ATP and 2 mentions for BioNexus Gene Lab. Agape ATP's average media sentiment score of 1.22 beat BioNexus Gene Lab's score of 0.93 indicating that Agape ATP is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
BioNexus Gene Lab	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Agape ATP	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

BioNexus Gene Lab has a beta of 4.06, meaning that its stock price is 306% more volatile than the broader market. Comparatively, Agape ATP has a beta of 0.05, meaning that its stock price is 95% less volatile than the broader market.

Agape ATP has lower revenue, but higher earnings than BioNexus Gene Lab. Agape ATP is trading at a lower price-to-earnings ratio than BioNexus Gene Lab, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BioNexus Gene Lab	$7.43M	0.73	-$2.98M	-$1.48	N/A
Agape ATP	$1.52M	2.72	-$2.28M	-$1.33	N/A

18.9% of BioNexus Gene Lab shares are held by institutional investors. Comparatively, 0.0% of Agape ATP shares are held by institutional investors. 0.1% of BioNexus Gene Lab shares are held by insiders. Comparatively, 2.0% of Agape ATP shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BioNexus Gene Lab	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Agape ATP	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

BioNexus Gene Lab has a net margin of -54.70% compared to Agape ATP's net margin of -125.89%. Agape ATP's return on equity of -8.43% beat BioNexus Gene Lab's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
BioNexus Gene Lab	-54.70%	-37.43%	-32.88%
Agape ATP	-125.89%	-8.43%	-7.75%

Summary

Agape ATP beats BioNexus Gene Lab on 8 of the 13 factors compared between the two stocks.

Get Agape ATP News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ATPC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ATPC vs. The Competition

Export

Metric	Agape ATP	MED PRODUCTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$4.14M	$8.10B	$6.31B	$12.61B
Dividend Yield	N/A	2.54%	2.68%	5.22%
P/E Ratio	-3.11	15.07	21.13	26.68
Price / Sales	2.72	7.86	546.66	114.79
Price / Cash	N/A	17.57	27.44	37.60
Price / Book	0.18	3.61	9.95	6.88
Net Income	-$2.28M	$224.05M	$3.56B	$336.73M
7 Day Performance	48.92%	2.40%	2.19%	4.20%
1 Month Performance	N/A	N/A	N/A	-0.08%
1 Year Performance	-95.16%	2.75%	36.31%	40.26%

Agape ATP Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ATPC Agape ATP	1.2024 of 5 stars	$4.14 -15.0%	N/A	-94.3%	$4.14M	$1.52M	N/A	40	Positive News Short Interest Decrease Gap Up Trading Halted
ACON Aclarion	3.338 of 5 stars	$3.19 -0.3%	N/A	-48.8%	$7.88M	$80K	N/A	7	Positive News Analyst Forecast Gap Down
MGRX Mangoceuticals	1.1176 of 5 stars	$0.43 +3.4%	N/A	-79.4%	$7.01M	$460K	N/A	3	Analyst Upgrade Gap Down
MRAI Marpai	N/A	$0.26 -2.9%	N/A	-43.4%	$6.64M	$34.87M	N/A	150
ADVB Advanced Biomed	1.3641 of 5 stars	$4.44 +0.5%	N/A	N/A	$6.11M	N/A	0.92	40	Positive News Short Interest Decrease

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ATPC) was last updated on 6/1/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Agape ATP (ATPC) Competitors

ATPC vs. ACON, MGRX, MRAI, ADVB, and BGLC

How does Agape ATP compare to Aclarion?

Summary

How does Agape ATP compare to Mangoceuticals?

Summary

How does Agape ATP compare to Marpai?

Summary

How does Agape ATP compare to Advanced Biomed?

Summary

How does Agape ATP compare to BioNexus Gene Lab?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ATPC vs. The Competition

Agape ATP Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Agape ATP (ATPC) Competitors

ATPC vs. ACON, MGRX, MRAI, ADVB, and BGLC

How does Agape ATP compare to Aclarion?

Is ATPC or ACON more profitable?

Do analysts rate ATPC or ACON?

Do institutionals and insiders have more ownership in ATPC or ACON?

Which has higher valuation and earnings, ATPC or ACON?

Does the media refer more to ATPC or ACON?

Which has more risk & volatility, ATPC or ACON?

Summary

How does Agape ATP compare to Mangoceuticals?

Does the media prefer MGRX or ATPC?

Which has stronger valuation and earnings, MGRX or ATPC?

Is MGRX or ATPC more profitable?

Which has more volatility and risk, MGRX or ATPC?

Do insiders and institutionals have more ownership in MGRX or ATPC?

Do analysts prefer MGRX or ATPC?

Summary

How does Agape ATP compare to Marpai?

Which has preferable valuation and earnings, ATPC or MRAI?

Is ATPC or MRAI more profitable?

Do institutionals and insiders hold more shares of ATPC or MRAI?

Which has more risk & volatility, ATPC or MRAI?

Does the media favor ATPC or MRAI?

Do analysts recommend ATPC or MRAI?

Summary

How does Agape ATP compare to Advanced Biomed?

Which has more volatility and risk, ATPC or ADVB?

Is ATPC or ADVB more profitable?

Do institutionals & insiders have more ownership in ATPC or ADVB?

Do analysts prefer ATPC or ADVB?

Which has preferable earnings and valuation, ATPC or ADVB?

Does the media favor ATPC or ADVB?

Summary

How does Agape ATP compare to BioNexus Gene Lab?

Does the media prefer BGLC or ATPC?

Which has more volatility & risk, BGLC or ATPC?

Which has higher earnings and valuation, BGLC or ATPC?

Do insiders and institutionals have more ownership in BGLC or ATPC?

Do analysts rate BGLC or ATPC?

Is BGLC or ATPC more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ATPC vs. The Competition

Agape ATP Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools